Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979) |
---|
06/19/2013 | EP2603501A1 Heterocyclic antiviral compounds |
06/19/2013 | EP2603493A1 Phenalkylamine derivatives, pharmaceutical compositions containing them, and their use in therapy |
06/19/2013 | EP2603218A1 Quinolyl amines as kinase inhibitors |
06/19/2013 | EP2603079A1 Positive allosteric modulators of mglur2 |
06/19/2013 | CN1950343B Basic amine compound and use thereof |
06/19/2013 | CN103168033A Quinazoline compounds as sodium channel blockers |
06/19/2013 | CN103168031A Tetrahydroquinoline derivatives used as AMPK activators |
06/19/2013 | CN103168029A Salts and polymorphs of sulfamide ns3 inhibitors |
06/19/2013 | CN103159742A 5-Chloropyrimidine compound and application of 5-Chloropyrimidine compound serving as epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor |
06/19/2013 | CN103159740A Preparation and application of 1, 5-distributed-1, 2, 3-triazole trifluoromethyl type compound |
06/19/2013 | CN103159739A 1, 4-disubstituted-1, 2, 3-triazole compounds and preparation method thereof |
06/19/2013 | CN103159738A Mixed aromatic compound of alkynyl bridging and application thereof |
06/19/2013 | CN103159737A Esomeprazole sodium compound and medicine composition |
06/19/2013 | CN103159736A Substitutional pyrazol kinase inhibitor |
06/19/2013 | CN103159735A Substitutional imidazole kinase inhibitor |
06/19/2013 | CN103159692A Tetrazole-substituted arylamides |
06/19/2013 | CN103159667A 6-guanidyl-2H-isoindole compound as well as preparation method and application thereof |
06/19/2013 | CN103159665A Isatin-5-amide inhibiting agent with inhibition effect against SARS coronavirus main protease |
06/19/2013 | CN102391250B Dabigatran compound and preparation method and medicinal composition thereof |
06/19/2013 | CN102285969B N-1-substituted piperidin-4-arylamine derivatives and preparation method and use thereof |
06/19/2013 | CN102225931B Amino acid ester-containing bivalent cis-neonicotinoid compound and its preparation method and application |
06/19/2013 | CN102206203B Synthesis of benzimidazole-containing naphthalimide derivatives and applications of benzimidazole-containing naphthalimide derivatives on cancer resistance |
06/19/2013 | CN102167695B Benzimidazole-carbonyl-pyridine-amino-ehtyl-propionate hemihyrate and its use |
06/19/2013 | CN101880276B Substituted diazepan compounds as orexin receptor antagonists |
06/19/2013 | CN101735197B Method for synthesizing Imatinib |
06/19/2013 | CN101678214B 芳基醚哒嗪酮衍生物 Aryl ether pyridazinones |
06/19/2013 | CN101627027B 氨基吡唑激酶抑制剂 Aminopyrazole kinase inhibitors |
06/19/2013 | CN101450939B Novel benzimidazoles compounds |
06/19/2013 | CN101072759B Triazole compounds that modulate HSP90 activity |
06/18/2013 | US8466288 Isoindolinone inhibitors of phosphatidylinositol 3-kinase |
06/18/2013 | US8466176 Fungicide hydroximoyl-tetrazole derivatives |
06/18/2013 | US8466175 Form of S-omeprazole |
06/18/2013 | US8466173 Crystal forms of (3R)-1-(2-methylalanyl-D-tryptophyl)-3-(phenylmethyl)-3-piperidinecarboxylic acid 1,2,2-trimethylhydrazide |
06/18/2013 | US8466165 4-phenylamino-quinazolin-6-yl-amides |
06/18/2013 | US8466162 5-alkynyl-pyridines |
06/18/2013 | US8466161 Hydroxamate derivative, a production method for the same, and a pharmaceutical composition comprising the same |
06/18/2013 | US8466157 Proteasome inhibitors having chymotrypsin-like activity |
06/18/2013 | US8466149 6-substituted sulfonyl azabicyclo[3.2.1]octanes useful to inhibit 11β-hydroxysteroid dehydrogenase type-I |
06/18/2013 | US8466148 1,2-disubstituted heterocyclic compounds |
06/18/2013 | CA2595218C Indole derivatives having inhibitory activity against sodium-dependent glucose transporter |
06/18/2013 | CA2567506C Cyclic amide derivatives, and their production and use as antithrombotic agents |
06/18/2013 | CA2566898C Tri- and bi-cyclic heteroaryl histamine-3 receptor ligands |
06/18/2013 | CA2560896C Imidazole compounds |
06/13/2013 | WO2013086229A1 Bicyclic aryl and heteroaryl sodium channel inhibitors |
06/13/2013 | WO2013085957A1 Substituted piperidinyl-pyridazinyl derivatives useful as scd 1 inhibitors |
06/13/2013 | WO2013085954A1 Substituted piperidinyl-carboxamide derivatives useful as scd 1 inhibitors |
06/13/2013 | WO2013085018A1 Phenylpyrrole derivative |
06/13/2013 | WO2013085017A1 Pyridone derivative and medicine containing same |
06/13/2013 | WO2013085016A1 Pyridone derivative and medicine containing same |
06/13/2013 | WO2013084484A1 Material for organic electroluminescent element and organic electroluminescent element using same |
06/13/2013 | WO2013084241A1 Compounds as inhibitors of renin |
06/13/2013 | WO2013084138A1 Cyclic urea derivatives as androgen receptor antagonists |
06/13/2013 | WO2013083774A1 Herbicidal compounds |
06/13/2013 | WO2013083604A1 Kinase inhibitors |
06/13/2013 | WO2013083591A1 Substituted pyrazoles as mglu5 receptor modulators |
06/13/2013 | WO2013056684A3 Thiazole derivative as dhodh inhibitor and use thereof |
06/13/2013 | WO2013015657A3 Novel compound having angiogenesis inhibitory activity, method for preparing same, and pharmaceutical composition comprising same |
06/13/2013 | WO2013002592A3 Method for purifying high-purity betulonic acid, method for preparing piperazine betulonic acid amide derivative using high-purity betulonic acid and derivative thereof, and method for purifying high-purity boc-lysinated betulonic acid using high-purity betulonic acid |
06/13/2013 | WO2012177893A3 Trpm8 antagonists and their use in treatments |
06/13/2013 | US20130150588 Salts and Polymorphs of Dexrabeprazole |
06/13/2013 | US20130150586 Process for producing 1-triazole-2-butanol derivatives |
06/13/2013 | US20130150578 Novel hypoglycemic compounds |
06/13/2013 | US20130150409 Novel trpv3 modulators |
06/13/2013 | US20130150408 Substituted dioxopiperidinyl phthalimide derivatives |
06/13/2013 | US20130150407 Piperidinyl naphthylacetic acids |
06/13/2013 | US20130150404 Biphenyl derivatives |
06/13/2013 | US20130150391 Piperidinyl Pyrimidine Amides As KV7 Potassium Channel Openers |
06/13/2013 | US20130150390 Therapeutic or prophylactic agent for allergic dermatitis |
06/13/2013 | US20130150377 Tetrahydropyridinyl and Dihydropyrrolyl Compounds and the Use Thereof |
06/13/2013 | US20130150374 Arylalkylamine compound and process for preparing the same |
06/13/2013 | US20130150373 Nicotinic receptor compounds |
06/13/2013 | US20130150372 4-phenoxy-nicotinamide or 4-phenoxy-pyrimidine-5-carboxamide compounds |
06/13/2013 | US20130150369 Benzotriazine Oxides as Drugs Targeting Mycobacterium Tuberculosis |
06/13/2013 | US20130150368 Certain amino-pyridines and amino-triazines, compositions thereof, and methods for their use |
06/13/2013 | US20130150367 Carboxamide compounds and their use as calpain inhibitors |
06/13/2013 | US20130150366 Chemical compounds |
06/13/2013 | US20130150365 Insecticidal Triazines and Pyrimidines |
06/13/2013 | US20130150358 Theramutein modulators |
06/13/2013 | US20130150356 Acyl Piperazine Derivatives as TTX-S Blockers |
06/13/2013 | US20130150355 Novel compounds |
06/13/2013 | US20130150354 New selective ccr2 antagonists |
06/13/2013 | US20130150350 Derivatives of 1-Phenyl-1,5-Dihydro-Benzo[B] [1,4]Diazepine-2,4-Dione as Inhibitors of HIV Replication |
06/13/2013 | US20130150349 2,4-pyrimidinediamine compounds and their uses |
06/13/2013 | US20130150347 Novel compounds |
06/13/2013 | US20130150346 Use of FAAH Inhibitors for Treating Parkinson's Disease and Restless Legs Syndrome |
06/13/2013 | US20130150344 Heterocyclic compound |
06/13/2013 | US20130150343 Kinase inhibitors |
06/13/2013 | US20130150341 Novel compounds |
06/13/2013 | US20130150339 Bicyclic Aryl and Heteroaryl Sodium Channel Inhibitors |
06/13/2013 | US20130150333 Modulators of retinoid-related orphan receptor gamma |
06/13/2013 | US20130150326 Autotaxin inhibitors and uses thereof |
06/13/2013 | US20130150325 3-(Fluorovinyl)pyrazoles and their use |
06/13/2013 | US20130150281 Polymeric prodrug with self-immolative linker |
06/13/2013 | US20130149346 Dabigatran etexilate-containing pharmaceutical composition |
06/13/2013 | CA2858752A1 1-substituted 4-arylpiperazines as kappa opioid receptor antagonists |
06/13/2013 | CA2858447A1 Kinase inhibitors |
06/13/2013 | CA2858342A1 Phenylpyrrole derivative |
06/13/2013 | CA2858164A1 Pyridone derivative and medicine containing same |
06/13/2013 | CA2855351A1 Novel pyrrole derivatives |
06/13/2013 | CA2854608A1 Herbicidal compounds |